The account-based marketing checklist: 25 things to have in place for healthcare and life sciences in the DACH region
A single-page checklist to audit whether your account-based marketing setup is production-grade or a science project. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the DACH region.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the DACH region. In this market, DACH buyers reward rigour, documentation, and long-cycle trust — not urgency-led campaigns, so the way you install account-based marketing has to be shaped to that reality from day one.
Use this as a pre-flight before you commit spend to account-based marketing. Each item takes minutes to check and hours to fix later.
List, trigger, message. If any of the three is generic, stop and fix the generic one before you touch the other two. Generic list plus sharp message beats sharp list plus generic message, but only for a week.
Owner, cadence, metric. One named human owns the model. The cadence is written down. Pipeline created inside the named-account list is the number in every review.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the DACH region it is compounded by the fact that trust-building cycle length, not intent is what actually gates growth. Account-based marketing is only useful here when it is pointed at both constraints at once.
Data, tooling, workflow. Data flows to one place. Tooling is minimal. Workflow survives the owner going on holiday.
Quality gate, kill criteria, learning loop. Nothing ships without a human eyeballing it. Anything below the bar dies inside a week. What you learn feeds Monday.
Ethics, brand, deliverability. You will not do anything on this list you would not want on the front page. Brand is protected. Sending infrastructure is separated from the primary domain.
Governance, budget, escalation path. Someone above the owner cares. Budget is finite and defended. Bad news travels up in hours, not weeks.
If more than three of these are missing, account-based marketing is not going to produce a durable pipeline created inside the named-account list. Fix them in order and re-run the checklist in a month.
Concretely for healthcare and life sciences in the DACH region: the healthcare teams that install this get past procurement instead of dying in it, and one properly-run DACH account survives leadership changes and compounds for years. That is the reason it is worth installing account-based marketing deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
ABM · healthcare · DACH — answered
- Does account-based marketing work for healthcare and life sciences in the DACH region?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the DACH region, DACH buyers reward rigour, documentation, and long-cycle trust — not urgency-led campaigns. The healthcare teams that install this get past procurement instead of dying in it.
- How often should I run this checklist?
- Quarterly, plus any time you change ownership, tooling, or budget for account-based marketing.
- What is the single most important item?
- A named owner. Every other item is meaningless without one.
- What if I fail more than three items?
- Pause the spend, fix them in order, and restart at low volume rather than push through.
- Does this checklist apply at enterprise scale?
- Yes — the items are the same. Governance and escalation matter more at scale.
- What is the DACH-specific pitfall when running account-based marketing for healthcare?
- Importing a playbook that was built for another market. In the DACH region, DACH buyers reward rigour, documentation, and long-cycle trust — not urgency-led campaigns — the install has to reflect that.
Growth Broker editorial
Filed under abm · healthcare · dach